Stroke

Adults with OCD were more than 3 times as likely to have an ischemic stroke after age 40 than those without the disorder, according to a study published in Stroke.

Preliminary findings being presented at the International Stroke Conference 2021 show some of the same risk factors associated with stroke in older adults also cause stroke in younger adults.

International Stroke Conference 2021: A new analysis of the landmark REDUCE-IT trial found that adding icosapent ethyl to treatment regimens that already include statins further reduces stroke risk.

Stroke patients are nearly 50% more likely vs heart attack patients to develop depression, according to new research being presented at the upcoming International Stroke Conference.

FDA approval is based on results of the phase III THALES trial, in which DAPT with ticagrelor and aspirin for 30 days reduced the rate of stroke and death by 17% vs aspirin alone.

New research shows nearly 30% of US young adults do not know the 5 most common stroke symptoms, almost 3 million are not aware of any symptoms.

A new study found a significant association between increased stroke risk and dual use of e-cigarettes and traditional cigarettes-authors urging physicians to use results as a wake-up call.

Two studies to be presented at the upcoming AHA annual meeting found that young cannabis users are at greater risk for stroke and arrhythmia. 

A new study reveals the notable impact of the variation in published stroke rates on the net clinical benefit of anticoagulation in atrial fibrillation.

Is there a link between stroke knowledge and OAC preferences in patients with AF? According to a new study, yes. 

The path to reducing risk of stroke in AF patients is far from straight and narrow. A case and 3 questions test your clinical navigation skills.

In these complicated patients, should warfarin or a novel oral anticoagulant be chosen for stroke prevention?